Search Results 281-290 of 16277 for monoclonal antibody
Ixekizumab is a recombinant high-affinity fully human monoclonal antibody that targets IL-17A Immunoglobulin gamma-1 (IgG1)/kappa-class. The purpose of this ...
Immunotherapy with monoclonal antibodies, such as nivolumab, may help ... monoclonal antibody including nivolumab and/or any of its excipients. Severe ...
Monoclonal antibodies, such as rituximab, interfere with the ability of cancer cells to grow and spread. It is not yet known whether fludarabine phosphate ...
Monoclonal antibodies, such as pembrolizumab, may interfere with the ... Has had a prior anti-cancer monoclonal antibody (mAb) ≤4 weeks prior to ...
Toripalimab-tpzi is a monoclonal antibody that changes the immune system to help control the growth of cancer cells. This medicine is to be given only by or ...
Nivolumab is a monoclonal antibody that affects the immune system and helps control the growth of cancer cells. This medicine is to be given only by or ...
Monoclonal antibody treatment helps couple recover quickly from COVID-19. Dan Lea. February 23, 2021. First · Previous ... 298 · 299 · 300 · 301 · 302 · 303 ...
The impact of prior treatment with a CD19 targeting monoclonal antibody on subsequent treatment with CD19 targeting CART cell therapy in preclinical models ...
These previous treatments include a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody. This medicine is available only ...
What's the latest on monoclonal antibody therapies to treat COVID-19? Adam Harringa. January 12, 2022. COVID-19. What is 'flurona' and why a Mayo Clinic expert ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Their crucial work saves lives every day. Let Mayo Clinic researchers know they’re appreciated with a quick message.